CV-8102 clinical trials
Also written CV8102.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2014
How each study uses CV-8102 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- CV8102
- 2
Studies by the year they started
3 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2017 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Often tested with
Tested in the same studies.
Therapeutic Liver Cancer Peptide Vaccine IMA970A (1) · Rabies virus strain flury LEP antigen (propiolactone inactivated) (1)
Studies
Open first, then newest update. How each study uses CV-8102 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACCStatus unknownPhase 1CureVacNCT03291002Written as CV8102How we know
- IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma PatientsCompletedPhase 1/2National Cancer Institute, NaplesNCT03203005Written as IMA970A plus CV8102 and CyclophosphamideHow we know
- Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy AdultsCompletedPhase 1CureVacNCT02238756Written as CV8102How we know
Codes
What other systems call CV-8102 · ClinicalTrials.gg INT018139
- UNII (FDA) ULM5THL8W5CV-8102One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | ULM5THL8W5 | CV-8102 | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.